UNS 0.00% 0.5¢ unilife corporation

http://www.hikma.com/~/media/Files/H/Hikma/Attachments/pdf/report...

  1. 268 Posts.
    http://www.hikma.com/~/media/Files/...orts/financial-reports/annual-report-2014.pdf

    Page 30,
    Strengthening and
    broadening our
    product portfolio
    3 Submitted 165 products across all our markets
    3 Signed three new in-licence agreements
    3 Received approval for first biosimilar product, Remsima,
    in-licensed from Celltrion
    3 Submitted first product in a pre-filled syringe
    to the US FDA
    3 Increase investment in internal R&D
    3 Re-launch the first Bedford products to the US market
    3 Submit additional products in pre-filled syringes
    Maintaining high
 
watchlist Created with Sketch. Add UNS (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.